JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB76055

Anti-E Cadherin antibody [M168] - C-terminal

4

(18 Reviews)

|

(482 Publications)

Anti-E Cadherin antibody [M168] - C-terminal (ab76055) is a mouse monoclonal antibody detecting E Cadherin in Western Blot, Flow Cytometry (Intra), IHC-P. Suitable for Human.

- Over 400 publications
- Trusted since 2009

View Alternative Names

CD324, Cadherin-1, ARC-1, Epithelial cadherin, Uvomorulin, E-cadherin, Cdh1

8 Images
Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
  • WB

Supplier Data

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)

Blocked and probed in the presence of 5% milk, and the image was captured using chemiluminescence and film.

Lane 1:

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (ab76055) at 1/1000 dilution

Lane 2:

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (ab76055) at 1/2000 dilution

Lane 3:

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (ab76055) at 1/4000 dilution

All lanes:

A431 (Human epidermoid carcinoma cell line) denatured whole cell lysate at 10 µg

Predicted band size: 97 kDa

false

Exposure time: 2min

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
  • IHC-P

PubMed

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)

Immunohistochemistry staining of E Cadherin in human MMCR (Muller's muscle conjunctival resection) tissue.

Xylene and rehydration with serial ethanol dilutions were used for deparaffinization. Slides were washed twice for 5 minutes in 0.25% Triton X-100 for permeabilization and blocked for 2 hours at room temperature with 2% BSA and 10% normal donkey serum in PBS. Slides were incubated overnight at 4°C with ab76055. The next day, the slides were washed twice for 5 minutes in PBS and incubated for 1–2 hours with respective secondary antibodies diluted in blocking solution (1 : 200–800). Vecta shield mounting medium with 4′,6-diamidino-2-phenylindole (DAPI) was placed over the slides and covered with a glass coverslip. Slides were analyzed using the Zeiss LSM 710 Confocal Microscope.

Shah et al PLoS One. 2016 Jan 29;11(1):e0148018. doi: 10.1371/journal.pone.0148018. eCollection 2016. Fig 2. Reproduced under the Creative Commons license https://creativecommons.org/publicdomain/zero/1.0/

Immunocytochemistry - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
  • ICC

Lab

Immunocytochemistry - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)

ICC/IF image of ab76055 stained A431 (Human epidermoid carcinoma cell line) cells.

The cells were 4% formaldehyde fixed (10 minutes) and then incubated in 1% BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1 hour to permeabilize the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab76055, 1/100 dilution) overnight at +4°C. The secondary antibody (green) was ab96879, DyLight® 488 goat anti-mouse IgG (H+L) used at a 1/250 dilution for 1 hour. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1 hour. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43 μM.

Flow Cytometry (Intracellular) - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)

Overlay histogram showing A431 (Human epidermoid carcinoma cell line) cells stained with ab76055 (red line).

The cells were fixed with 4% paraformaldehyde (10 minutes) and then permeabilized with 0.1% PBS-Tween for 20 minutes. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76055, 1/100 dilution) for 30 minutes at 22°C. The secondary antibody used was a DyLight® 488 goat anti-mouse IgG (H+L) ab96879 at 1/500 dilution for 30 minutes at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2 μg/1x106 cells) used under the same conditions.

Acquisition of >5,000 events was performed.

This antibody gave a positive signal in A431 cells fixed with 80% methanol (5 minutes)/permeabilized with 0.1% PBS-Tween for 20 minutes used under the same conditions.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)

IHC image of E Cadherin staining in human colon formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F.

The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer pH 6, for 20 minutes. The section was then incubated with ab76055, 5 μg/ml, for 15 minutes at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
  • WB

CiteAb

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)

Western Blotting using Anti-E Cadherin antibody [M168] - C-terminal, ab76055. Publication image from Redon, C. E. et al., 2016, Nat Commun, 26876487. Legend direct from paper.

Downregulation of the transcription factors Slug and ZEB1 reverses the EMT programme induced by H2A.X deficiency.(a) Control cells (shCTRL) and cells silenced for H2A.X (shH2A.X) were transfected for 3 days with control siRNA (siC) or with a pool of siSLUG and siZEB1 (siS/Z). Immunoblot analysis of EMT markers was performed using tubulin as loading control. (b) Staining of E-cadherin and β-catenin by immunofluorescence in HCT116 control cells (shCTRL) and H2A.X-deficient cells (shH2A.X) transfected for 3 days with control siRNA (siC) or a pool of siRNAs against SLUG and ZEB1 (siS/Z). Nuclei were counterstained with propidium iodide (red); scale bars, 20 µm. (c) Top panel, analysis of cell phenotypic changes through the staining of F-actin (phalloidin) by immunofluorescence using conditions described in b; scale bars, 20 µm. Bottom panel, photomicrographs of cells; scale bar, 100 µm.(d) Immunoblot analysis of EMT markers in HCT116 parental cells (WT) and H2A.X knockout cells (KO) transfected for 3 days with siRNA control (siC) or with a pool of siSLUG and siZEB1 (siS/Z) with tubulin-loading controls. H2A.X knockout cells were generated using CRISPR/Cas9 system for precise deletion of the H2A.X gene. cl.5, clone #5; and cl.6, clone #6. (e) Immunofluorescence assays showing E-cadherin and β-catenin staining. Cells were treated as in d. Nuclei were counterstained in red with propidium iodide; scale bars, 20 µm.

false

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
  • WB

CiteAb

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)

Western Blotting using Anti-E Cadherin antibody [M168] - C-terminal, ab76055. Publication image from Redon, C. E. et al., 2016, Nat Commun, 26876487. Legend direct from paper.

H2A.X re-expression inhibits EMT and promotes metastatic colonization in the lung.(a) Immunoblot analysis of EMT markers in HCT116 parental cells (WT), H2A.X knockout cells (KO) and H2A.X knockout cells in which H2A.X expression was restored (KO+H2A.X), utilizing actin as a loading control. (b) HCT116 parental cells (WT), H2A.X knockout cells (KO) and revertant cells (KO+H2A.X) were analysed for transcripts levels of EMT markers by real-time PCR. Expression values for E-cadherin (CDH1), ZEB1, Slug, Vimentin (VIM), integrin beta 4 (ITGB4) and versican (VCAN) were normalized to 18S RNA (gene/18S ratio). Error bars represent the s.e. (n=3). Statistical significance was determined by a two-tailed, unpaired Student's t-test. The experiments were repeated three times. (c). Immunostaining of the epithelial marker E-cadherin. Nuclei were counterstained in red with propidium iodide; scale bars, 20 µm. Photomicrographs of cells are shown (top panel); scale bar, 100 µm. (d) Tail vein injections of HCT116 parental cells (WT) and H2A.X knockout cells (KO) showed similar numbers of lung metastatic foci 4 weeks post injection. Ectopic expression of H2A.X (KO+H2A.X) resulted in a 2.5-fold increase in lung macroscopic metastases. (e) Representative haematoxylin- and eosin-stained lung sections from mice injected with HCT116 parental cells (WT), H2A.X knockout cells (KO) and H2A.X knockout cells in which H2A.X expression was restored (KO+H2A.X). Black arrows indicate some macroscopic lung nodules. Scale bars, 1 mm. Statistical significance was determined by a two-tailed, unpaired Student's t-test.

false

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
  • WB

CiteAb

Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)

Western Blotting using Anti-E Cadherin antibody [M168] - C-terminal, ab76055. Publication image from Redon, C. E. et al., 2016, Nat Commun, 26876487. Legend direct from paper.

Downregulation of the transcription factors Slug and ZEB1 reverses the EMT programme induced by H2A.X deficiency.(a) Control cells (shCTRL) and cells silenced for H2A.X (shH2A.X) were transfected for 3 days with control siRNA (siC) or with a pool of siSLUG and siZEB1 (siS/Z). Immunoblot analysis of EMT markers was performed using tubulin as loading control. (b) Staining of E-cadherin and β-catenin by immunofluorescence in HCT116 control cells (shCTRL) and H2A.X-deficient cells (shH2A.X) transfected for 3 days with control siRNA (siC) or a pool of siRNAs against SLUG and ZEB1 (siS/Z). Nuclei were counterstained with propidium iodide (red); scale bars, 20 µm. (c) Top panel, analysis of cell phenotypic changes through the staining of F-actin (phalloidin) by immunofluorescence using conditions described in b; scale bars, 20 µm. Bottom panel, photomicrographs of cells; scale bar, 100 µm.(d) Immunoblot analysis of EMT markers in HCT116 parental cells (WT) and H2A.X knockout cells (KO) transfected for 3 days with siRNA control (siC) or with a pool of siSLUG and siZEB1 (siS/Z) with tubulin-loading controls. H2A.X knockout cells were generated using CRISPR/Cas9 system for precise deletion of the H2A.X gene. cl.5, clone #5; and cl.6, clone #6. (e) Immunofluorescence assays showing E-cadherin and β-catenin staining. Cells were treated as in d. Nuclei were counterstained in red with propidium iodide; scale bars, 20 µm.

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

M168

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

WB, Flow Cyt (Intra), IHC-P, ICC

applications

Immunogen

Recombinant Fragment Protein within Mouse Cdh1. The exact immunogen used to generate this antibody is proprietary information.

P09803

Specificity

ab76055 does not cross react with VE Cadherin or N Cadherin.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/100 - 1/1000", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/100", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>" } } }

Product details

What is this antibody validated in?
Anti-E Cadherin antibody [M168] - C-terminal (ab76055) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of E Cadherin?
Anti-E Cadherin [M168] - C-terminal (ab76055) specifically detects a band for E Cadherin (UniProt: P09803) at a molecular weight of 97kDa.

Trusted by the scientific community
Anti-E Cadherin [M168] - C-terminal (ab76055) was first used in a scientific publication in 2009 and has been cited over 400 times in peer-reviewed journals.

Reviewed by scientists
Anti-E Cadherin [M168] - C-terminal (ab76055) has over 15 independent reviews from customers.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.05% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

E-Cadherin sometimes called CDH1 or Cadherin-1 is a protein that plays a role in cell-to-cell adhesion. This transmembrane protein has a molecular weight of approximately 120 kDa. E-Cadherin is mainly expressed in epithelial tissues of various organs including the skin and gut. Its adhesive function is made possible by its extracellular domain that facilitates homophilic binding between cells contributing to the maintenance of tissue architecture and cellular integrity.
Biological function summary

E-Cadherin participates in establishing and maintaining adherens junctions which are vital for tissue structure. E-Cadherin operates as a core component of the cadherin-catenin complex which links the protein to the actin cytoskeleton. Through this linkage E-Cadherin plays an important role in signaling pathways that influence cellular growth and differentiation. The protein's ability to mediate intercellular connections also regulates cellular motility and supports basic aspects of cell behavior in epithelial tissues.

Pathways

E-Cadherin influences both the Wnt signaling pathway and the epithelial-to-mesenchymal transition (EMT). Within the Wnt signaling pathway E-Cadherin partners with Β-catenin a significant player in transcription regulation and cell signaling. Disruption in E-Cadherin's adhesive functionality can lead to increased Β-catenin availability affecting downstream transcriptional control. In the EMT process E-Cadherin loss characterizes an important step in which cells gain migratory and invasive properties typically seen during metastasis in cancer progression.

E-Cadherin's role is prominent in cancer particularly in the context of gastric and breast cancers. Mutations or altered expression of E-Cadherin lead to diminished cell adhesion promoting tumorigenesis and metastatic spread. In gastric cancer for instance mutated E-Cadherin often associates with loss of epithelial function facilitating cancer cell dissemination. Additionally its loss or dysfunction may correlate with proteins such as Β-catenin further impacting cancer progression and pathology.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Cadherins are calcium-dependent cell adhesion proteins (PubMed : 11976333). They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. CDH1 is involved in mechanisms regulating cell-cell adhesions, mobility and proliferation of epithelial cells (PubMed : 11976333). Promotes organization of radial actin fiber structure and cellular response to contractile forces, via its interaction with AMOTL2 which facilitates anchoring of radial actin fibers to CDH1 junction complexes at the cell membrane (By similarity). Plays a role in the early stages of desmosome cell-cell junction formation via facilitating the recruitment of DSG2 and DSP to desmosome plaques (By similarity). Has a potent invasive suppressor role. It is a ligand for integrin alpha-E/beta-7 (By similarity).. E-Cad/CTF2 promotes non-amyloidogenic degradation of Abeta precursors. Has a strong inhibitory effect on APP C99 and C83 production (By similarity).. (Microbial infection) Does not function as a receptor for L.monocytogenes internalin A (InlA); mutating a single surface-exposed residue confers receptor activity to this protein and promotes uptake of the bacteria.
See full target information Cdh1

Publications (482)

Recent publications for all applications. Explore the full list and refine your search

Journal of inflammation research 18:13575-13592 PubMed41054626

2025

Sirp-α Antibody Inhibits Renal Cell Carcinoma Progression via Akt1/Akt2 Modulation in Tumor-Associated Macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Junfeng Hao,Naiquan Liu,Xin Huang,Hanlei Zhou,Hanrong Li,Yizhou Zhang,Bing Yu,Ziqian Bi,Xinyuan Song,Shunan Li,Keyu Chen,Ning Li,Chao Zhu,Jiahe Wang

World journal of surgical oncology 23:350 PubMed41024019

2025

SUZ12 knockdown restrains the proliferation, migration, and invasion of oral tongue squamous cell carcinoma through inhibiting DNMT1-mediated ZNF582 promoter methylation.

Applications

Unspecified application

Species

Unspecified reactive species

Xiangwei Kong,Yicheng Cheng,Lin Zhang,Wei Yin,Chenchen Wang,Zhan'ao Wu

Scientific reports 15:31927 PubMed40883446

2025

Choline transporter-like protein 1 in tongue squamous cell carcinoma: implications for cell proliferation and differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Nao Hashimoto,Kei Nakajima,Yoshihiko Akashi,Katsutoshi Kokubun,Keisuke Sugahara,Akira Katakura,Kenichi Matsuzaka

Hereditas 162:177 PubMed40883807

2025

RBM15 promotes COAD progression by regulating the m6A modification of TMC5.

Applications

Unspecified application

Species

Unspecified reactive species

Errong Tian,Li Gao,Lan Wu,Limin Qin

Journal of cellular and molecular medicine 29:e70695 PubMed40839490

2025

Comparative Analysis of miRNA Expression 106a-5p and 375-3p and Proteins ERK1/2, p38, β-Catenin and E-Cadherin in Prostate Cancer and Benign Prostatic Hyperplasia.

Applications

Unspecified application

Species

Unspecified reactive species

Magdalena Smereczańska,Natalia Domian,Grzegorz Młynarczyk,Irena Kasacka

Theranostics 15:7440-7453 PubMed40756363

2025

AI-powered 3D pathology protocol enhances enteric nervous system visualization and quantification for clinical diagnostics.

Applications

Unspecified application

Species

Unspecified reactive species

Young Hyun Yun,Kee Young Chung,Yunjoo Lee,Tae Sik Sung,Dayoung Ko,Seung-Bum Ryoo,Hyun-Young Kim,Kyu Joo Park,Jong Pil Im,Byeong Gwan Kim,Joo Sung Kim,Seong-Joon Koh,Hyung Jin Choi

Frontiers in oncology 15:1568367 PubMed40666104

2025

Hsa_circ_0001859 promotes NSCLC progression through the miRNA-101-3p/MMP1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jianxin Tan,Zhenyu Fan,Rongguo Lu,Shugao Ye

Pediatric discovery.. 2:e94 PubMed40626133

2025

SOX9 regulates epithelial-mesenchymal transformation by mediating the Wnt/-catenin signaling pathway in hypospadias.

Applications

Unspecified application

Species

Unspecified reactive species

Xueyu He,Zhicheng Zhang,Zhenmin Liu,Qiang Zhang,Chunlan Long,Lianju Shen,Guanghui Wei,Xing Liu

Cell death discovery 11:241 PubMed40382334

2025

Matrix metalloproteinase-10 promotes kidney fibrosis by transactivating β-catenin signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoli Sun,Qian Ren,Xi Liu,Huishi Tan,Zhanji Zhan,Enqing Lin,Yinyi Long,Xue Hong,Lili Zhou,Youhua Liu

American journal of translational research 17:1679-1693 PubMed40225990

2025

circRNA_0005927 inhibits gastric cancer metastasis by downregulating the miR-570-3p/FOXO3 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Gao Zhou,Jian Wen,Feng Lu,Jianhua Wang,Shuguang Tan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com